People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology, Other Technology, Software / Tech, Business Services, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vanqua Bio, Inc. | — | Biotechnology | Series C | $136.0M | $462.4M | 2019 |
| Peraso Inc. | — | Other Technology | Series A | $18.9M | $4.4M | 2024 |
| Rodeo Therapeutics Corp | — | Biotechnology | Series A | $14.3M | $323.6M | 2017 |
| ApoGen Biotechnologies, Inc. | — | Biotechnology | Series A | $7.6M | $273.5M | 2016 |
| Driven Software Solutions, Inc. | — | Software / Tech | Seed | $3.1M | $8.2M | 2023 |
| Incentone Inc | — | Business Services | Seed | $1.2M | $29.2M | 2013 |
| Chamishi Therapeutics, Inc. | — | Pharma | Pre-Seed | $490K | $23.2M | 2019 |
James Sullivan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Sullivan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 2 | 18 |
| Steve Gillis | 2 | 13 |
| Thong Le | 2 | 12 |
| Joel Marcus | 2 | 9 |
| Lindsay Rayle | 2 | 7 |
| David Schubert | 2 | 6 |
| Jonathan Silverstein | 1 | 10 |
| Stephen Squinto | 1 | 8 |
| Ian Howes | 1 | 5 |
| Joel Johnston Marcus | 1 | 5 |
| Kendall Mohler | 1 | 5 |
| John Santini | 1 | 5 |
| M. Johnston Erwin | 1 | 5 |
| BERNARD DAVITIAN | 1 | 4 |
| Sara Nayeem | 1 | 4 |
| Margarita Chavez | 1 | 4 |
| James Johnston Sullivan | 1 | 3 |
| Daniel Lewis | 1 | 3 |
| Maneesh Goyal | 1 | 3 |
| Jeffrey Margolis | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.